The
European Medicines Agency (EMA) has published recently an overview of existing
international regulatory initiatives for human medicines. The mapping was
carried out by EMA on behalf of the International Coalition of Medicines
Regulatory Authorities (ICMRA).
The
report lists all international projects and provides international regulatory
agencies with comprehensive details on the number and scope of global
initiatives that can support decision-making regarding future engagement,
prioritisation and coordination.
The
aim of the mapping exercise was to raise awareness of ongoing international
regulatory activities, help establish a basis for a more strategic coordination
to avoid duplication of efforts, and identify possible gaps.
Posted by Dr. Tim Sandle
